Elsevier Helps Biologists Understand Disease Biology More Quickly with the Launch of Pathway Studio Web

Cloud version of Pathway Studio helps users be more productive with new ease of use and performance features

New York, December 9, 2015

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced the launch of the next version of Pathway Studio Web, enabling researchers to more quickly understand the underlying biology of disease. This updated version of Pathway Studio Web is designed to be easier to use and is up to 30 times faster for common analysis tasks. These improvements are a direct result of customer feedback and market research and are designed to help researchers to quickly understand the complex underlying mechanisms of disease progression and response to treatments, while enabling the interactive visualization of gene expression, proteomics and metabolomics data.

The new web interface is simpler, with reorganized menus and extensive online help, making it easier for new users to be productive quickly. The number of “clicks” required to carry out common analysis tasks have been reduced – in some cases by 60 percent or more – speeding and simplifying workflows. And, to help researchers comb through the massive quantities of literature and research data, additional interactive filters have been added, allowing users to simply select or deselect types of entities and interactions, and apply dynamic confidence filters based on the number of independent publications supporting any given relationship. Together, these features help users of Elsevier’s Pathway Studio easily mine vast quantities of data to find the results relevant to their research, more easily and more quickly than any other solution.

“Our ongoing focus is ensuring that all scientists find Pathway Studio authoritative, flexible and easy to use, so that it naturally supports their particular workflows. Even if a user hasn’t used the tool for some time, it will be easy to jump right in and quickly perform effective analyses,” said Jaqui Hodgkinson, VP, Product Development, Biology Products, Elsevier. “We’ve worked closely with our customers to ensure that users of any expertise can easily dig deeply into their data. The interactive nature of the new user interface encourages exploration of their experimental data. The dramatic performance increases seen in this new version mean users can rapidly perform common pathway analysis tasks interactively, and significantly reduces analysis times with large data sets.”

New in this version is the interactive Network Builder wizard, which leads users easily through the process of creating new pathways. It includes powerful, easy-to-use filtering tools and shortcuts, designed to satisfy the needs of novice users while still maintaining advanced filter options for the power user. Updates are done in seconds, so users can see the exact results of their filtering and then export their results and pathways to Excel.

Users of Pathway Studio Web were automatically given access to the updated version from the 1st December 2015. It is available for free as a server update to Pathway Studio Enterprise customers.

For more information on enhanced features, please visit the ‘what’s new’ page, or visit the Pathway Studio site.


About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com

Media contact
Christopher Capot
Director, Corporate Relations
+1 917 704 5174